These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Familial hypodysfibrinogenaemia associated with second occurrence of gamma326 Cys-->Tyr mutation. Dear A, Brennan SO, George PM. Thromb Haemost; 2005 Mar; 93(3):612-3. PubMed ID: 15735819 [No Abstract] [Full Text] [Related]
4. A new heterozygous mutation in gamma fibrinogen gene leading to 326 Cys-->Ser substitution in fibrinogen Córdoba is associated with defective polymerization and familial hypodysfibrinogenemia. Guglielmone HA, Sanchez MC, Abate Daga D, Bocco JL. J Thromb Haemost; 2004 Feb; 2(2):352-4. PubMed ID: 14996011 [No Abstract] [Full Text] [Related]
5. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation. de Raucourt E, de Mazancourt P, Maghzal GJ, Brennan SO, Mosesson MW. Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237 [Abstract] [Full Text] [Related]
7. Congenital hypodysfibrinogenemia and abruptio placentae in a woman with history of cerebral thrombosis. Santoro R, Iannaccaro P, Sottilotta G. Acta Obstet Gynecol Scand; 2007 Nov; 86(2):247-8. PubMed ID: 17364292 [No Abstract] [Full Text] [Related]
10. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy. Sarode R, Rawal A, Lee R, Shen YM, Frenkel EP. Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834 [Abstract] [Full Text] [Related]
11. Congenital Hypodysfibrinogenemia due to γ326Cys→Tyr Mutation: Third Ever-Described Case Associated with Recurrent Venous Thrombosis and COVID Vaccine. Nanthan KR, Pedersen IS, Andersen DT, Bor MV. Acta Haematol; 2024 Mar; 147(5):564-570. PubMed ID: 39140696 [Abstract] [Full Text] [Related]
13. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis. Robert-Ebadi H, Le Querrec A, de Moerloose P, Gandon-Laloum S, Borel Derlon A, Neerman-Arbez M. Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913 [Abstract] [Full Text] [Related]
14. Portal vein thrombosis: an unexpected finding in a 28-year-old male with abdominal pain. Ferguson JL, Hennion DR. J Am Board Fam Med; 2008 Oct; 21(3):237-43. PubMed ID: 18467536 [Abstract] [Full Text] [Related]
15. [The prognostic value of thrombus precursor protein in the assessment of the probability for venous thrombosis recurrence after the completion of anticoagulatory therapy with warfarin]. Kozlova TV. Klin Med (Mosk); 2006 Oct; 84(12):51-3. PubMed ID: 17294885 [Abstract] [Full Text] [Related]
17. Characterisation of Fibrinogen Oslo IV by electrospray mass spectrometry. Brennan SO, Ridgway H, Stormorken H, Brosstad F, George PM. Thromb Haemost; 1997 May; 77(5):1040-1. PubMed ID: 9184429 [No Abstract] [Full Text] [Related]
18. Upper-extremity deep vein thrombosis in a patient on clozapine therapy carrying the prothrombin G20210A mutation. Vayá A, Lopez M, Plumé G, Ribes J. Pathophysiol Haemost Thromb; 2008 May; 36(2):105-7. PubMed ID: 19127092 [Abstract] [Full Text] [Related]
19. Fibrinogen γ' and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis. Smalberg JH, Koehler E, Darwish Murad S, Plessier A, Seijo S, Trebicka J, Primignani M, Rijken DC, de Maat MP, García-Pagán JC, Valla DC, Janssen HL, Leebeek FW, European Network for Vascular Disorders of the Liver (EN-Vie). Thromb Haemost; 2013 Mar; 109(3):558-60. PubMed ID: 23306717 [No Abstract] [Full Text] [Related]
20. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function. Undas A, Zdziarska J, Iwaniec T, Stepien E, Skotnicki AB, de Moerloose P, Neerman-Arbez M. Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]